BCL2 gene polymorphisms and splicing variants in chronic myeloid leukemia

Area of Science:

• Genetics
• Hematology
• Molecular Biology

Background:

• Constitutional genetic variations in the antiapoptotic BCL2 gene are implicated in hematological malignancies.
• Single nucleotide polymorphisms (SNPs) in BCL2 may influence chronic myeloid leukemia (CML) susceptibility and clinical outcomes.

Purpose of the Study:

• To investigate the association between BCL2 SNPs and CML risk.
• To determine if BCL2 polymorphisms influence CML characteristics at diagnosis.

Main Methods:

• Genotyping of four candidate BCL2 SNPs in CML patients and controls.
• Analysis of the association between BCL2 SNPs and CML risk.
• Correlation of BCL2 SNPs with clinical parameters like the Sokal score.
• Assessment of BCL2 alternative splicing transcripts (BCL2-α, BCL2-β) in relation to polymorphisms.

Main Results:

• No significant association was found between the studied BCL2 SNPs and the risk of developing CML.
• Two specific BCL2 SNPs (rs2279115 and rs1801018) were significantly associated with the Sokal score, a disease risk profile.
• These polymorphisms correlated with BCL2 splicing variants in healthy individuals but not in CML patients.
• BCL2 mRNA splicing variant levels changed during the clinical course of CML.

Conclusions:

• BCL2 gene polymorphisms do not appear to influence the susceptibility to CML.
• Specific BCL2 SNPs are associated with clinical features of CML at diagnosis.
• The underlying pathogenic mechanisms linking BCL2 polymorphisms to CML clinical characteristics require further investigation.